Bayer divests weed killers in Monsanto deal
Bayer aims to tackle the European Commission’s competition concerns about the chemical company’s acquisition of rival Monsanto by selling the non-selective herbicide and “LibertyLink” plant gene to BASF, subject to the enforcer’s approval of the Bayer/Monsanto deal.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.